Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.
Mazzi
B
B
Clerici
T D
TD
Zanussi
M
M
Lupo Stanghellini
M T
MT
Vago
L
L
Sironi
E
E
Peccatori
J
J
Bernardi
M
M
Carrera
P
P
Palini
A
A
Rossini
S
S
Bordignon
C
C
Bonini
C
C
Ferrari
M
M
Ciceri
F
F
Fleischhauer
K
K
D000293:Adolescent; D000328:Adult; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications / Q000235:genetics / Q000628:therapy; D006680:HLA Antigens / Q000235:genetics*; D019337:Hematologic Neoplasms / Q000150:complications* / Q000235:genetics / Q000628:therapy*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000235:genetics; D016133:Polymerase Chain Reaction; D012307:Risk Factors; D033581:Stem Cell Transplantation; D014019:Tissue Donors; D055815:Young Adult
D006680:HLA Antigens